These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25023913)

  • 1. Understanding regional variation in Medicare expenditures for initial episodes of prostate cancer care.
    Wang SY; Wang R; Yu JB; Ma X; Xu X; Kim SP; Soulos PR; Saraf A; Gross CP
    Med Care; 2014 Aug; 52(8):680-7. PubMed ID: 25023913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Patient Factors, Cancer Characteristics, and Treatment Patterns in the Cost of Care for Medicare Beneficiaries with Breast Cancer.
    Xu X; Herrin J; Soulos PR; Saraf A; Roberts KB; Killelea BK; Wang SY; Long JB; Wang R; Ma X; Gross CP
    Health Serv Res; 2016 Feb; 51(1):167-86. PubMed ID: 26119176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional Medicare Expenditures and Survival Among Older Women With Localized Breast Cancer.
    Tannenbaum S; Soulos PR; Herrin J; Mougalian S; Long JB; Wang R; Ma X; Gross CP; Xu X
    Med Care; 2017 Dec; 55(12):1030-1038. PubMed ID: 29068906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations Between End-of-Life Cancer Care Patterns and Medicare Expenditures.
    Wang SY; Hall J; Pollack CE; Adelson K; Davidoff AJ; Long JB; Gross CP
    J Natl Compr Canc Netw; 2016 Aug; 14(8):1001-8. PubMed ID: 27496116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localized prostate cancer: regional variation and national policy.
    Seidenwurm D; Logsdon M
    Med Care; 2014 Aug; 52(8):677-9. PubMed ID: 25023912
    [No Abstract]   [Full Text] [Related]  

  • 6. Hospital Variation in Spending for Lung Cancer Resection in Medicare Beneficiaries.
    Jean RA; Bongiovanni T; Soulos PR; Chiu AS; Herrin J; Kim N; Xu X; Kim AW; Gross CP
    Ann Thorac Surg; 2019 Dec; 108(6):1710-1716. PubMed ID: 31400321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost implications of prostate cancer screening in the Medicare population.
    Ma X; Wang R; Long JB; Ross JS; Soulos PR; Yu JB; Makarov DV; Gold HT; Gross CP
    Cancer; 2014 Jan; 120(1):96-102. PubMed ID: 24122801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of regional Medicare expenditures for otolaryngology physician services.
    Smith A; Handorf E; Arjmand E; Lango MN
    Laryngoscope; 2017 Jun; 127(6):1312-1317. PubMed ID: 27859299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longer Periods Of Hospice Service Associated With Lower End-Of-Life Spending In Regions With High Expenditures.
    Wang S; Hsu SH; Huang S; Soulos PR; Gross CP
    Health Aff (Millwood); 2017 Feb; 36(2):328-336. PubMed ID: 28167723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physician and facility drivers of spending variation in locoregional prostate cancer.
    Rodin D; Chien AT; Ellimoottil C; Nguyen PL; Kakani P; Mossanen M; Rosenthal M; Landrum MB; Sinaiko AD
    Cancer; 2020 Apr; 126(8):1622-1631. PubMed ID: 31977081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between regional per capita Medicare expenditures and patient perceptions of quality of care.
    Fowler FJ; Gallagher PM; Anthony DL; Larsen K; Skinner JS
    JAMA; 2008 May; 299(20):2406-12. PubMed ID: 18505950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of trends in the cost of initial cancer treatment.
    Warren JL; Yabroff KR; Meekins A; Topor M; Lamont EB; Brown ML
    J Natl Cancer Inst; 2008 Jun; 100(12):888-97. PubMed ID: 18544740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends and variations in utilization and costs of radiotherapy for prostate cancer: A SEER medicare analysis from 2007 through 2016.
    Mukherjee K; Small W; Duszak R
    Brachytherapy; 2022; 21(1):12-21. PubMed ID: 34380592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in end-of-life care and health care spending in women with uterine cancer.
    Margolis B; Chen L; Accordino MK; Clarke Hillyer G; Hou JY; Tergas AI; Burke WM; Neugut AI; Ananth CV; Hershman DL; Wright JD
    Am J Obstet Gynecol; 2017 Oct; 217(4):434.e1-434.e10. PubMed ID: 28709581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geographic variations in the cost of treating condition-specific episodes of care among Medicare patients.
    Reschovsky JD; Hadley J; O'Malley AJ; Landon BE
    Health Serv Res; 2014 Feb; 49(1):32-51. PubMed ID: 23829388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of medical expenditures in the last 6 months of life.
    Kelley AS; Ettner SL; Morrison RS; Du Q; Wenger NS; Sarkisian CA
    Ann Intern Med; 2011 Feb; 154(4):235-42. PubMed ID: 21320939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating Costs of Care Attributable to Cancer: Does the Choice of Comparison Group Matter?
    Chen AB; Li L; Cronin AM; Brooks GA; Kavanagh BD; Schrag D
    Health Serv Res; 2018 Aug; 53 Suppl 1(Suppl Suppl 1):3227-3244. PubMed ID: 28858372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Geographic variation in Medicare home health expenditures.
    Schuldt RF; Lallier ALM; Chen HF; Tilford JM
    Am J Manag Care; 2022 Jul; 28(7):322-328. PubMed ID: 35852881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total Medicare Costs Associated With Diagnosis and Treatment of Prostate Cancer in Elderly Men.
    Trogdon JG; Falchook AD; Basak R; Carpenter WR; Chen RC
    JAMA Oncol; 2019 Jan; 5(1):60-66. PubMed ID: 30242397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospital quality, patient risk, and Medicare expenditures for cancer surgery.
    Shubeck SP; Thumma JR; Dimick JB; Nathan H
    Cancer; 2018 Feb; 124(4):826-832. PubMed ID: 29149478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.